Ehlers-Danlos Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
With the skin hyperextensibility, joint hypermobility, papyraceous scar revealed by physical examination, and the heterozygous pathogenic variant c1997G > A (p.P659P) in COL5A2 gene revealed by whole exome sequencing, the diagnosis of the classical Ehlers-Danlos syndrome was made.
|
31517854 |
2019 |
Ehlers-Danlos Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Results thus suggest that COL5A2(+/-) humans, although unlikely to present with frank classic Ehlers-Danlos syndrome, are likely to have fragile connective tissues with increased susceptibility to trauma and certain chronic pathologic conditions.
|
25987251 |
2015 |
Ehlers-Danlos Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Col5a2, a gene previously not specifically linked to MI response but responsible for the classic type of Ehlers-Danlos syndrome, was found to have many and strong co-expression associations within this community (11 connections with ρ > 0.85).
|
23574622 |
2013 |
Ehlers-Danlos Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
We analyzed COL5A1 and COL5A2 in 126 patients with a diagnosis or suspicion of classic EDS.
|
22696272 |
2012 |
Ehlers-Danlos Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The classic subtype of EDS is caused by mutations in one of the type V collagen genes (COL5A1 and COL5A2).
|
21611149 |
2011 |
Ehlers-Danlos Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
However, because no prospective molecular studies of COL5A1 and COL5A2 have been performed in a clinically well-defined patient group, this number may underestimate the real proportion of patients with classic Ehlers-Danlos syndrome harboring a mutation in one of these genes.
|
20847697 |
2010 |
Ehlers-Danlos Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in COL5A1 and COL5A2, encoding the type V collagen proalpha1- and proalpha2-chain, are found in approximately 50% of patients with classic EDS.
|
18972565 |
2009 |
Ehlers-Danlos Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Seven patients with classic Ehlers-Danlos syndrome (EDS) due to COL5A1 haploinsufficiency and one with an exon-skipping mutation in COL5A2 underwent an ocular examination, corneal topography, pachymetry, and specular microscopy.
|
16431952 |
2006 |
Ehlers-Danlos Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the COL5A1 and the COL5A2 gene encoding the alpha1(V) and the alpha2(V) chains, respectively, of type V collagen have been shown to cause the disorder, but it is unknown what proportion of classic EDS patients carries a mutation in these genes.
|
15580559 |
2005 |
Ehlers-Danlos Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our findings show that heterozygous mutations of the COL5A2 gene can produce the EDS type I phenotype.
|
9425231 |
1998 |
Ehlers-Danlos Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Here we characterise a COL5A2 mutation in an EDS II family.
|
9783710 |
1998 |
Ehlers-Danlos Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
However, linkage studies in other EDS I families indicate the disorder is heterogeneous; linkage to both COL5A1 and COL5A2 was excluded in two other families with EDS I while a fourth family was concordant for linkage to COL5A1 (Z = 2.11; theta = 0.00).
|
8923000 |
1996 |